ArticleDysphagia2026
The Effectiveness of Botulinum Toxin Injection for Cricopharyngeal Dysfunction-Related Dysphagia in Nasopharyngeal Carcinoma Patients.
Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the effectiveness of botulinum toxin injection in improving swallowing function in patients with cricopharyngeal muscle dysfunction (CPMD) following radiotherapy for nasopharyngeal carcinoma (NPC). Cohort study. Outpatients with NPC-related CPMD receiving endoscopy-guided botulinum toxin injection at National Cheng Kung University Hospital between 2017-2024. 15 NPC patients with CPMD were enrolled. Swallowing function was assessed using the functional oral intake scale (FOIS), penetration-aspiration scale (PAS), bolus residue scale (BRS), dynamic imaging grade of swallowing toxicity (DIGEST), normalized residue ratio scale for vallecular (NRRS_V) and pyriform sinus (NRRS_P), laryngeal elevation, epiglottic retroflexion, pharyngeal contraction ratio(PCR), bolus clearance ratio (BCR), and temporal swallowing parameters (oral transit time [OTT], pharyngeal response time [PRT], pharyngeal delay time [PDT], pharyngeal transit time [PTT], laryngeal elevation delay time [LEDT]). The Wilcoxon signed-rank test was used to compare pre- and post-injection data. FOIS significantly improved after botulinum toxin injection (p = 0.0002). Objective measures showed a significant reduction in NRRS_P (p = 0.0067). Temporal characteristics also demonstrated significant improvement in OTT, PRT, and PTT (p = 0.0156, p = 0.0303, p = 0.0284, respectively). However, other objective measures showed no significant changes. Botulinum toxin injection may benefit specific swallowing parameters, such as NRRS_P, OTT, PTT, and PRT, and enhance FOIS in NPC patients with radiation-induced CPMD. However, its overall impact on swallowing function remains uncertain.
Indexed as
Identifiers
40773044What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.